Kopp Family Office

Latest statistics and disclosures from Kopp Family Office's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NEO, HZNP, VCEL, FIVN, XENT, and represent 100.00% of Kopp Family Office's stock portfolio.
  • Reduced shares in these 5 stocks: HZNP (-$10.59B), FIVN (-$7.16B), NEO (-$3.26B), VCEL (-$606.42M), XENT (-$439.76M).
  • Kopp Family Office was a net seller of stock by $22.05B.
  • Kopp Family Office has $185.09M in assets under management (AUM), dropping by -0.01%.

Portfolio Holdings for Kopp Family Office

Companies in the Kopp Family Office portfolio as of the June 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
NeoGenomics Com New (NEO) 78.03 $144.42M -95% 4.66M 30.98
Horizon Therapeutics Public Limited Company SHS (HZNP) 9.50 $17.58M -99% 316.32k 55.58
Vericel (VCEL) 8.08 $14.95M -97% 1.08M 13.82
Five9 (FIVN) 3.83 $7.08M -99% 63.99k 110.66
Intersect Ent (XENT) 0.57 $1.05M -99% 77.63k 13.54

Past Filings by Kopp Family Office

SEC 13F filings are viewable for Kopp Family Office going back to 2019